Index by author

August 07, 2018; Volume 13,Issue 8

A

  1. Abramowitz, Matthew K.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  2. Abreo, Kenneth

    1. Drug-Coated Balloon Angioplasty for Hemodialysis Fistula Maintenance
      Bharat Sachdeva and Kenneth Abreo
      CJASN August 2018, 13 (8) 1140-1141; DOI: https://doi.org/10.2215/CJN.07360618

  3. Albright, Robert C.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  4. Alexander, G. Caleb

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

B

  1. Bain, James R.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  2. Beaudry, Alain

    1. Cost of Dialysis Therapy by Modality in Manitoba
      Cost of Dialysis Therapy by Modality in Manitoba
      Alain Beaudry, Thomas W. Ferguson, Claudio Rigatto, Navdeep Tangri, Sandi Dumanski and Paul Komenda
      CJASN August 2018, 13 (8) 1197-1203; DOI: https://doi.org/10.2215/CJN.10180917

  3. Beck, Gerald J.

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  4. Betjes, Michiel G.H.

    1. ABO-Incompatible Kidney Transplant Outcomes
      ABO-Incompatible Kidney Transplant Outcomes
      Annelies E. de Weerd and Michiel G.H. Betjes
      CJASN August 2018, 13 (8) 1234-1243; DOI: https://doi.org/10.2215/CJN.00540118

  5. Bieber, Scott D.

    1. Open Access
      Telehealth and Home Dialysis
      Scott D. Bieber and Daniel E. Weiner
      CJASN August 2018, 13 (8) 1288-1290; DOI: https://doi.org/10.2215/CJN.03010318

  6. Blake, Peter G.

    1. Open Access
      Urgent Start Peritoneal Dialysis
      Peter G. Blake and Arsh K. Jain
      CJASN August 2018, 13 (8) 1278-1279; DOI: https://doi.org/10.2215/CJN.02820318

  7. Brown, Landon

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  8. Bungum, Lisa A.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

C

  1. Carland, Jane E.

    1. Open Access
      Clinical Pharmacokinetics in Kidney Disease
      Darren M. Roberts, Jacob Sevastos, Jane E. Carland, Sophie L. Stocker and Tom N. Lea-Henry
      CJASN August 2018, 13 (8) 1254-1263; DOI: https://doi.org/10.2215/CJN.05150418

  2. Chang, Alex R.

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

  3. Chebib, Fouad T.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  4. Chen, Joy Chieh-Yu

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  5. Chettiar, Alexis

    1. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Alexis Chettiar, Maria Montez-Rath, Sai Liu, Yoshio N. Hall, Ann M. O’Hare and Manjula Kurella Tamura
      CJASN August 2018, 13 (8) 1180-1187; DOI: https://doi.org/10.2215/CJN.00180118

  6. Cohen, Robert A.

    1. Communication Strategies to Address Conflict about Dialysis Decision Making for Critically Ill Patients
      Jane O. Schell and Robert A. Cohen
      CJASN August 2018, 13 (8) 1248-1250; DOI: https://doi.org/10.2215/CJN.00010118

  7. Corcoran, David L.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  8. Coresh, Josef

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

  9. Czerwiec, Frank S.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

D

  1. D’Uscio, Margaret M.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  2. de Boer, Ian H.

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  3. de Weerd, Annelies E.

    1. ABO-Incompatible Kidney Transplant Outcomes
      ABO-Incompatible Kidney Transplant Outcomes
      Annelies E. de Weerd and Michiel G.H. Betjes
      CJASN August 2018, 13 (8) 1234-1243; DOI: https://doi.org/10.2215/CJN.00540118

  4. Dillon, John J.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  5. Dumanski, Sandi

    1. Cost of Dialysis Therapy by Modality in Manitoba
      Cost of Dialysis Therapy by Modality in Manitoba
      Alain Beaudry, Thomas W. Ferguson, Claudio Rigatto, Navdeep Tangri, Sandi Dumanski and Paul Komenda
      CJASN August 2018, 13 (8) 1197-1203; DOI: https://doi.org/10.2215/CJN.10180917

E

  1. Edwards, Marie E.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  2. Eilers, Denise

    1. Open Access
      Person-Centered Approach to Deciding on Long-Term Dialysis
      Denise Eilers
      CJASN August 2018, 13 (8) 1133-1134; DOI: https://doi.org/10.2215/CJN.07300618

  3. El-Zoghby, Ziad M.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

F

  1. Feely, Molly A.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  2. Ferguson, Thomas W.

    1. Cost of Dialysis Therapy by Modality in Manitoba
      Cost of Dialysis Therapy by Modality in Manitoba
      Alain Beaudry, Thomas W. Ferguson, Claudio Rigatto, Navdeep Tangri, Sandi Dumanski and Paul Komenda
      CJASN August 2018, 13 (8) 1197-1203; DOI: https://doi.org/10.2215/CJN.10180917

  3. Fishbane, Steven

    1. Open Access
      Opportunities for Increasing the Rate of Preemptive Kidney Transplantation
      Steven Fishbane and Vinay Nair
      CJASN August 2018, 13 (8) 1280-1282; DOI: https://doi.org/10.2215/CJN.02480218
    2. Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Open Access
      Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Steven Fishbane, Bhupinder Singh, Seema Kumbhat, Wayne A. Wisemandle and Nancy E. Martin
      CJASN August 2018, 13 (8) 1204-1214; DOI: https://doi.org/10.2215/CJN.11631017

G

  1. Glazier, Alexandra K.

    1. Open Access
      Organ Donation and the Principles of Gift Law
      Alexandra K. Glazier
      CJASN August 2018, 13 (8) 1283-1284; DOI: https://doi.org/10.2215/CJN.03740318

  2. Gossett, Christy L.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  3. Grams, Morgan E.

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

  4. Grubbs, Vanessa

    1. Meeting the Palliative Care Needs of Maintenance Hemodialysis Patients
      Vanessa Grubbs
      CJASN August 2018, 13 (8) 1138-1139; DOI: https://doi.org/10.2215/CJN.07390618

  5. Gu, Weiyue

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  6. Guo, Ruikun

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  7. Gurley, Susan

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

H

  1. Hall, Yoshio N.

    1. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Alexis Chettiar, Maria Montez-Rath, Sai Liu, Yoshio N. Hall, Ann M. O’Hare and Manjula Kurella Tamura
      CJASN August 2018, 13 (8) 1180-1187; DOI: https://doi.org/10.2215/CJN.00180118

  2. Han, Qianqian

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  3. Harris, Peter C.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  4. He, Changzheng

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  5. Henderson, Clark M.

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  6. Hickson, LaTonya J.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  7. Himmelfarb, Jonathan

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  8. Hogan, Marie C.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  9. Hoofnagle, Andrew N.

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  10. Hostetter, Thomas H.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

I

  1. Imrey, Peter B.

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  2. Inker, Lesley A.

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

  3. Irazabal, Maria V.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

J

  1. Jain, Arsh K.

    1. Open Access
      Urgent Start Peritoneal Dialysis
      Peter G. Blake and Arsh K. Jain
      CJASN August 2018, 13 (8) 1278-1279; DOI: https://doi.org/10.2215/CJN.02820318

  2. Jefferson, J. Ashley

    1. Complications of Immunosuppression in Glomerular Disease
      J. Ashley Jefferson
      CJASN August 2018, 13 (8) 1264-1275; DOI: https://doi.org/10.2215/CJN.01920218

K

  1. Kannam, Allison

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

  2. Kestenbaum, Bryan

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017
    2. Proximal Tubular Secretory Clearance
      Ke Wang and Bryan Kestenbaum
      CJASN August 2018, 13 (8) 1291-1296; DOI: https://doi.org/10.2215/CJN.12001017

  3. Kestenbaum, Bryan R.

    1. Commentary on Complications of Immunosuppressive Treatments for Glomerulonephritis
      Bryan R. Kestenbaum and Stephen L. Seliger
      CJASN August 2018, 13 (8) 1276-1277; DOI: https://doi.org/10.2215/CJN.07610618

  4. Ketchum, Christian J.

    1. Open Access
      Rebuilding the Pipeline of Investigators in Nephrology Research in the United States
      Jenna M. Norton, Christian J. Ketchum, Tracy L. Rankin and Robert A. Star
      CJASN August 2018, 13 (8) 1285-1287; DOI: https://doi.org/10.2215/CJN.03360318

  5. Kline, Timothy L.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  6. Komenda, Paul

    1. Cost of Dialysis Therapy by Modality in Manitoba
      Cost of Dialysis Therapy by Modality in Manitoba
      Alain Beaudry, Thomas W. Ferguson, Claudio Rigatto, Navdeep Tangri, Sandi Dumanski and Paul Komenda
      CJASN August 2018, 13 (8) 1197-1203; DOI: https://doi.org/10.2215/CJN.10180917

  7. Kumbhat, Seema

    1. Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Open Access
      Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Steven Fishbane, Bhupinder Singh, Seema Kumbhat, Wayne A. Wisemandle and Nancy E. Martin
      CJASN August 2018, 13 (8) 1204-1214; DOI: https://doi.org/10.2215/CJN.11631017

  8. Kurella Tamura, Manjula

    1. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Alexis Chettiar, Maria Montez-Rath, Sai Liu, Yoshio N. Hall, Ann M. O’Hare and Manjula Kurella Tamura
      CJASN August 2018, 13 (8) 1180-1187; DOI: https://doi.org/10.2215/CJN.00180118

L

  1. Ladin, Keren

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

  2. Lawson, Jeffrey

    1. Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Open Access
      Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Scott O. Trerotola, Jeffrey Lawson, Prabir Roy-Chaudhury and Theodore F. Saad; for the Lutonix AV Clinical Trial Investigators
      CJASN August 2018, 13 (8) 1215-1224; DOI: https://doi.org/10.2215/CJN.14231217

  3. Lea-Henry, Tom N.

    1. Open Access
      Clinical Pharmacokinetics in Kidney Disease
      Darren M. Roberts, Jacob Sevastos, Jane E. Carland, Sophie L. Stocker and Tom N. Lea-Henry
      CJASN August 2018, 13 (8) 1254-1263; DOI: https://doi.org/10.2215/CJN.05150418

  4. Li, Hanyu

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  5. Li, Li

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  6. Liu, Fang

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  7. Liu, Sai

    1. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Alexis Chettiar, Maria Montez-Rath, Sai Liu, Yoshio N. Hall, Ann M. O’Hare and Manjula Kurella Tamura
      CJASN August 2018, 13 (8) 1180-1187; DOI: https://doi.org/10.2215/CJN.00180118

  8. Locke, Jayme E.

    1. Expand the Pool of Living Donors for Kidney Transplantation
      Jayme E. Locke
      CJASN August 2018, 13 (8) 1142-1143; DOI: https://doi.org/10.2215/CJN.07310618

  9. Loke, Rohini

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

M

  1. M. O’Connell, Thomas

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  2. Mannon, Roslyn Bernstein

    1. Thrombotic Microangiopathy in a Transplant Recipient
      Venkat Ram Rakesh Mundra and Roslyn Bernstein Mannon
      CJASN August 2018, 13 (8) 1251-1253; DOI: https://doi.org/10.2215/CJN.00020118

  3. Martin, Nancy E.

    1. Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Open Access
      Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Steven Fishbane, Bhupinder Singh, Seema Kumbhat, Wayne A. Wisemandle and Nancy E. Martin
      CJASN August 2018, 13 (8) 1204-1214; DOI: https://doi.org/10.2215/CJN.11631017

  4. Mc Causland, Finnian R.

    1. Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension
      Patrick B. Reeves and Finnian R. Mc Causland
      CJASN August 2018, 13 (8) 1297-1303; DOI: https://doi.org/10.2215/CJN.12141017

  5. Melamed, Michal L.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  6. Metzger, Andrew J.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  7. Meyer, Klemens B.

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

  8. Montez-Rath, Maria

    1. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Alexis Chettiar, Maria Montez-Rath, Sai Liu, Yoshio N. Hall, Ann M. O’Hare and Manjula Kurella Tamura
      CJASN August 2018, 13 (8) 1180-1187; DOI: https://doi.org/10.2215/CJN.00180118

  9. Muehlbauer, Michael J.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  10. Mundra, Venkat Ram Rakesh

    1. Thrombotic Microangiopathy in a Transplant Recipient
      Venkat Ram Rakesh Mundra and Roslyn Bernstein Mannon
      CJASN August 2018, 13 (8) 1251-1253; DOI: https://doi.org/10.2215/CJN.00020118

N

  1. Nair, Vinay

    1. Open Access
      Opportunities for Increasing the Rate of Preemptive Kidney Transplantation
      Steven Fishbane and Vinay Nair
      CJASN August 2018, 13 (8) 1280-1282; DOI: https://doi.org/10.2215/CJN.02480218

  2. Norby, Suzanne M.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  3. Norton, Jenna M.

    1. Open Access
      Rebuilding the Pipeline of Investigators in Nephrology Research in the United States
      Jenna M. Norton, Christian J. Ketchum, Tracy L. Rankin and Robert A. Star
      CJASN August 2018, 13 (8) 1285-1287; DOI: https://doi.org/10.2215/CJN.03360318

O

  1. O’Hare, Ann M.

    1. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease
      Alexis Chettiar, Maria Montez-Rath, Sai Liu, Yoshio N. Hall, Ann M. O’Hare and Manjula Kurella Tamura
      CJASN August 2018, 13 (8) 1180-1187; DOI: https://doi.org/10.2215/CJN.00180118

  2. O’Neal, Sara K.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  3. Ofstie, Troy G.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  4. Onuigbo, Macaulay

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  5. Oskoui, Tira

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

P

  1. Pandya, Renuka

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

  2. Perrone, Ronald D.

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

R

  1. Rankin, Tracy L.

    1. Open Access
      Rebuilding the Pipeline of Investigators in Nephrology Research in the United States
      Jenna M. Norton, Christian J. Ketchum, Tracy L. Rankin and Robert A. Star
      CJASN August 2018, 13 (8) 1285-1287; DOI: https://doi.org/10.2215/CJN.03360318

  2. Reeves, Patrick B.

    1. Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension
      Patrick B. Reeves and Finnian R. Mc Causland
      CJASN August 2018, 13 (8) 1297-1303; DOI: https://doi.org/10.2215/CJN.12141017

  3. Rich, Stephen S.

    1. Genetic Contribution to Risk for Diabetic Kidney Disease
      Stephen S. Rich
      CJASN August 2018, 13 (8) 1135-1137; DOI: https://doi.org/10.2215/CJN.07240618

  4. Rigatto, Claudio

    1. Cost of Dialysis Therapy by Modality in Manitoba
      Cost of Dialysis Therapy by Modality in Manitoba
      Alain Beaudry, Thomas W. Ferguson, Claudio Rigatto, Navdeep Tangri, Sandi Dumanski and Paul Komenda
      CJASN August 2018, 13 (8) 1197-1203; DOI: https://doi.org/10.2215/CJN.10180917

  5. Roberts, Darren M.

    1. Open Access
      Clinical Pharmacokinetics in Kidney Disease
      Darren M. Roberts, Jacob Sevastos, Jane E. Carland, Sophie L. Stocker and Tom N. Lea-Henry
      CJASN August 2018, 13 (8) 1254-1263; DOI: https://doi.org/10.2215/CJN.05150418

  6. Robinson-Cohen, Cassianne

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  7. Roy-Chaudhury, Prabir

    1. Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Open Access
      Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Scott O. Trerotola, Jeffrey Lawson, Prabir Roy-Chaudhury and Theodore F. Saad; for the Lutonix AV Clinical Trial Investigators
      CJASN August 2018, 13 (8) 1215-1224; DOI: https://doi.org/10.2215/CJN.14231217

S

  1. Saad, Theodore F.

    1. Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Open Access
      Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Scott O. Trerotola, Jeffrey Lawson, Prabir Roy-Chaudhury and Theodore F. Saad; for the Lutonix AV Clinical Trial Investigators
      CJASN August 2018, 13 (8) 1215-1224; DOI: https://doi.org/10.2215/CJN.14231217

  2. Sachdeva, Bharat

    1. Drug-Coated Balloon Angioplasty for Hemodialysis Fistula Maintenance
      Bharat Sachdeva and Kenneth Abreo
      CJASN August 2018, 13 (8) 1140-1141; DOI: https://doi.org/10.2215/CJN.07360618

  3. Schell, Jane O.

    1. Communication Strategies to Address Conflict about Dialysis Decision Making for Critically Ill Patients
      Jane O. Schell and Robert A. Cohen
      CJASN August 2018, 13 (8) 1248-1250; DOI: https://doi.org/10.2215/CJN.00010118

  4. Scialla, Julia J.

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  5. Secora, Alex

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

  6. Seliger, Stephen L.

    1. Commentary on Complications of Immunosuppressive Treatments for Glomerulonephritis
      Bryan R. Kestenbaum and Stephen L. Seliger
      CJASN August 2018, 13 (8) 1276-1277; DOI: https://doi.org/10.2215/CJN.07610618

  7. Senum, Sarah R.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  8. Sevastos, Jacob

    1. Open Access
      Clinical Pharmacokinetics in Kidney Disease
      Darren M. Roberts, Jacob Sevastos, Jane E. Carland, Sophie L. Stocker and Tom N. Lea-Henry
      CJASN August 2018, 13 (8) 1254-1263; DOI: https://doi.org/10.2215/CJN.05150418

  9. Shin, Jung-Im

    1. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
      Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
      CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

  10. Shiu, Yan-Ting

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  11. Singh, Bhupinder

    1. Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Open Access
      Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Steven Fishbane, Bhupinder Singh, Seema Kumbhat, Wayne A. Wisemandle and Nancy E. Martin
      CJASN August 2018, 13 (8) 1204-1214; DOI: https://doi.org/10.2215/CJN.11631017

  12. Star, Robert A.

    1. Open Access
      Rebuilding the Pipeline of Investigators in Nephrology Research in the United States
      Jenna M. Norton, Christian J. Ketchum, Tracy L. Rankin and Robert A. Star
      CJASN August 2018, 13 (8) 1285-1287; DOI: https://doi.org/10.2215/CJN.03360318

  13. Stocker, Sophie L.

    1. Open Access
      Clinical Pharmacokinetics in Kidney Disease
      Darren M. Roberts, Jacob Sevastos, Jane E. Carland, Sophie L. Stocker and Tom N. Lea-Henry
      CJASN August 2018, 13 (8) 1254-1263; DOI: https://doi.org/10.2215/CJN.05150418

T

  1. Tang, Xi

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  2. Tangri, Navdeep

    1. Cost of Dialysis Therapy by Modality in Manitoba
      Cost of Dialysis Therapy by Modality in Manitoba
      Alain Beaudry, Thomas W. Ferguson, Claudio Rigatto, Navdeep Tangri, Sandi Dumanski and Paul Komenda
      CJASN August 2018, 13 (8) 1197-1203; DOI: https://doi.org/10.2215/CJN.10180917

  3. Teng, Geer

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  4. Thorsteinsdottir, Bjorg

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  5. Torres, Vicente E.

    1. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
      Marie E. Edwards, Fouad T. Chebib, Maria V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad M. El-Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec and Vicente E. Torres
      CJASN August 2018, 13 (8) 1153-1161; DOI: https://doi.org/10.2215/CJN.01520218

  6. Trerotola, Scott O.

    1. Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Open Access
      Drug Coated Balloon Angioplasty in Failing AV Fistulas
      Scott O. Trerotola, Jeffrey Lawson, Prabir Roy-Chaudhury and Theodore F. Saad; for the Lutonix AV Clinical Trial Investigators
      CJASN August 2018, 13 (8) 1215-1224; DOI: https://doi.org/10.2215/CJN.14231217

V

  1. Vaisar, Tomas

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  2. Vaughan, Lisa E.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

W

  1. Wang, Ke

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017
    2. Proximal Tubular Secretory Clearance
      Ke Wang and Bryan Kestenbaum
      CJASN August 2018, 13 (8) 1291-1296; DOI: https://doi.org/10.2215/CJN.12001017

  2. Wang, Shanshan

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  3. Wang, Tingli

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  4. Wang, Yiting

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  5. Weiner, Daniel E.

    1. Open Access
      Telehealth and Home Dialysis
      Scott D. Bieber and Daniel E. Weiner
      CJASN August 2018, 13 (8) 1288-1290; DOI: https://doi.org/10.2215/CJN.03010318
    2. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

  6. Williams, Amy W.

    1. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
      Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson
      CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

  7. Wisemandle, Wayne A.

    1. Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Open Access
      Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
      Steven Fishbane, Bhupinder Singh, Seema Kumbhat, Wayne A. Wisemandle and Nancy E. Martin
      CJASN August 2018, 13 (8) 1204-1214; DOI: https://doi.org/10.2215/CJN.11631017

  8. Wolf, Myles

    1. Metabolic Changes with Base-Loading in CKD
      Julia J. Scialla, Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, Thomas M. O’Connell, Myles Wolf, Michal L. Melamed, Thomas H. Hostetter and Matthew K. Abramowitz
      CJASN August 2018, 13 (8) 1244-1246; DOI: https://doi.org/10.2215/CJN.01830218

  9. Wong, John B.

    1. Characterizing Approaches to Dialysis Decision Making with Older Adults
      Open Access
      Characterizing Approaches to Dialysis Decision Making with Older Adults
      Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner and John B. Wong
      CJASN August 2018, 13 (8) 1188-1196; DOI: https://doi.org/10.2215/CJN.01740218

Z

  1. Zelnick, Leila R.

    1. Alteration of HDL Protein Composition with Hemodialysis Initiation
      Alteration of HDL Protein Composition with Hemodialysis Initiation
      Ke Wang, Leila R. Zelnick, Andrew N. Hoofnagle, Tomas Vaisar, Clark M. Henderson, Peter B. Imrey, Cassianne Robinson-Cohen, Ian H. de Boer, Yan-Ting Shiu, Jonathan Himmelfarb, Gerald J. Beck and Bryan Kestenbaum; on behalf of the HFM Study
      CJASN August 2018, 13 (8) 1225-1233; DOI: https://doi.org/10.2215/CJN.11321017

  2. Zhang, Jie

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  3. Zhang, Junlin

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  4. Zhang, Rui

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

  5. Zhao, Yingwang

    1. <em>COL4A3</em> Gene Variants and Diabetic Kidney Disease in MODY
      COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
      Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu
      CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817
Back to top

In this issue

View Selected Citations (0)